Page last updated: 2024-08-26

mci 9038 and Embolism, Pulmonary

mci 9038 has been researched along with Embolism, Pulmonary in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19902 (9.09)18.7374
1990's0 (0.00)18.2507
2000's9 (40.91)29.6817
2010's7 (31.82)24.3611
2020's4 (18.18)2.80

Authors

AuthorsStudies
Akiyama, T; Gohma, I; Kohata, H; Kohno, M; Kumasawa, J; Nagata, T; Nishida, K; Ogawa, Y1
Daniels, LM; Sagardia, LM1
Enright, H; Fahy, A; McGlynn, F; McGrath, J; McHugh, J; Ryan, B; Varghese, C1
Gandotra, P; Garra, G; Gruberg, L; Selim, S; Supariwala, A1
Ahmed, MI; Bethea, BT; Elliot, JW; Richardson, JB1
Gamberini, L; Laici, C; Loforte, A; Ravaioli, M; Siniscalchi, A1
Dai, G; Liu, Q; Sun, L; Wang, C1
Pötzsch, B1
Burger, CF; Schlesinger, JJ1
Bhalla, MC; Frey, JA; Hourmouzis, Z; Jwayyed, S1
Jiji, RS; Michaels, AD1
Fries, D1
Knovich, MA; Lesser, GJ; Strowd, RE1
Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R1
Aizawa, Y; Fuse, I; Hanzawa, K; Hayashi, J; Higuchi, K; Hori, T; Matsubara, T; Mezaki, T; Moro, H; Nasuno, A; Tanaka, K; Tanaka, T; Tsuchida, K1
Hayashi, T; Kaneko, M; Nakao, Y; Nomura, T; Nonaka, Y; Okamura, J; Suyama, Y1
Hursting, MJ; Kelton, JG; Lewis, BE; Matthai, WH1
Rice, L1
Kaneko, M; Kohno, H; Muraoka, M; Shikata, H1
Durr, EA; Krueger, CD; Shapiro, NL1
Abiko, Y; Kumada, T1
Abiko, Y; Hara, T; Iwamoto, M; Kumada, T; Ogawa, H; Tomikawa, M1

Reviews

3 review(s) available for mci 9038 and Embolism, Pulmonary

ArticleYear
[Anticoagulation].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013, Volume: 108, Issue:4

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Arginine; Arrhythmias, Cardiac; Blood Coagulation Tests; Factor Xa Inhibitors; Hemorrhage; Heparin; Heparinoids; Hirudins; Humans; Infusions, Intravenous; Orthopedic Procedures; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Secondary Prevention; Sulfonamides; Thromboembolism; Treatment Outcome; Venous Thrombosis; Vitamin K

2013
[Anticoagulation in critically ill patient].
    Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:19-20

    Topics: Anticoagulants; Arginine; Biological Availability; Blood Coagulation Tests; Contraindications; Critical Care; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Pulmonary Embolism; Risk Factors; Sepsis; Shock, Septic; Sulfonamides; Venous Thrombosis

2009
Evolving management strategies for heparin-induced thrombocytopenia.
    Seminars in hematology, 2005, Volume: 42, Issue:3 Suppl 3

    Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Warfarin

2005

Trials

1 trial(s) available for mci 9038 and Embolism, Pulmonary

ArticleYear
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
    Thrombosis research, 2005, Volume: 116, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Arginine; Coronary Disease; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis

2005

Other Studies

18 other study(ies) available for mci 9038 and Embolism, Pulmonary

ArticleYear
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
    Journal of thrombosis and thrombolysis, 2020, Volume: 50, Issue:4

    Topics: Adult; Anticoagulants; Antithrombins; Arginine; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID-19; Heparin; Host-Pathogen Interactions; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombocytopenia; Treatment Outcome

2020
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, 11-16, Volume: 77, Issue:23

    Topics: Adult; Anticoagulants; Arginine; Coronavirus Infections; COVID-19; Fibrinolytic Agents; Heart Arrest; Heparin, Low-Molecular-Weight; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; Sulfonamides; Thrombolytic Therapy; Treatment Failure; Treatment Outcome

2020
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection.
    Journal of thrombosis and thrombolysis, 2021, Volume: 51, Issue:1

    Topics: Adult; Anticoagulants; Arginine; Catheter Obstruction; COVID-19; Drug Resistance; Drug Substitution; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Respiration, Artificial; SARS-CoV-2; Sulfonamides; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome

2021
Aortic Arch Thrombus and Pulmonary Embolism in a COVID-19 Patient.
    The Journal of emergency medicine, 2021, Volume: 60, Issue:2

    Topics: Anticoagulants; Antithrombins; Aorta, Thoracic; Arginine; Biomarkers; COVID-19; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombosis

2021
Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2017, Aug-01, Volume: 74, Issue:15

    Topics: Aged; Arginine; Catheterization; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Interventional

2017
Thrombolysis for acute pulmonary embolism after major hepatic surgery.
    Journal of clinical anesthesia, 2017, Volume: 42

    Topics: Acute Disease; Adenocarcinoma; Appendiceal Neoplasms; Arginine; Atrial Fibrillation; Bronchoscopy; Catheters; Colectomy; Computed Tomography Angiography; Diagnosis, Differential; Electric Countershock; Fibrinolytic Agents; Heparin; Hepatectomy; Humans; Infusions, Intravenous; Intubation, Intratracheal; Liver Neoplasms; Lung; Male; Middle Aged; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Troponin I; Ultrasonography; Venous Thrombosis

2017
Application of thrombelastography in primary total knee and total hip replacement: a prospective 87 patients study.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:6

    Topics: Anticoagulants; Arginine; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Care; Pipecolic Acids; Postoperative Care; Preoperative Care; Prospective Studies; Prothrombin Time; Pulmonary Embolism; Rivaroxaban; Sulfonamides; Thrombelastography; Thrombophilia; Venous Thrombosis

2019
Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:2

    Topics: Aged; Anticoagulants; Antithrombins; Arginine; Cardiac Surgical Procedures; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin

2014
Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban.
    The American journal of emergency medicine, 2015, Volume: 33, Issue:5

    Topics: Antithrombins; Arginine; Female; Fibrinolytic Agents; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Tissue Plasminogen Activator

2015
Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Nov-15, Volume: 72, Issue:6

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Disseminated Intravascular Coagulation; Embolectomy; Heparin; Humans; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Tomography, X-Ray Computed; Vena Cava Filters

2008
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
    Current treatment options in oncology, 2012, Volume: 13, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin

2012
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
    The American journal of the medical sciences, 2002, Volume: 324, Issue:5

    Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Treatment Failure; Treatment Outcome; Venous Thrombosis; Warfarin

2002
Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome.
    Circulation journal : official journal of the Japanese Circulation Society, 2003, Volume: 67, Issue:1

    Topics: Acute Disease; Anticoagulants; Arginine; Catheterization; Catheterization, Central Venous; Coated Materials, Biocompatible; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Radionuclide Imaging; Sulfonamides; Syndrome; Thrombocytopenia; Thromboembolism; Tomography, X-Ray Computed; Ultrasonography

2003
Heparin-induced thrombocytopenia and thrombosis in a patient with polycythemia vera.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:7

    Topics: Aged; Arginine; Female; Follow-Up Studies; Heparin; Humans; Japan; Pipecolic Acids; Polycythemia Vera; Pulmonary Embolism; Risk Assessment; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome

2004
[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2006, Volume: 47, Issue:8

    Topics: Aged; Antibodies; Arginine; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin

2006
Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Pharmacotherapy, 2006, Volume: 26, Issue:12

    Topics: Adult; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Obesity, Morbid; Partial Thromboplastin Time; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin

2006
Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals.
    Thrombosis research, 1981, Nov-15, Volume: 24, Issue:4

    Topics: Acute Disease; Animals; Antibodies, Anti-Idiotypic; Antigens; Antithrombin III; Arginine; Blood Coagulation Tests; Fibrinolytic Agents; Heparin; Male; Mice; Mice, Inbred Strains; Pipecolic Acids; Pulmonary Embolism; Rabbits; Rats; Rats, Inbred Strains; Sulfonamides; Thrombin; Thrombophlebitis

1981
[Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models].
    Rinsho byori. The Japanese journal of clinical pathology, 1987, Volume: Spec No 73

    Topics: Acute Disease; Animals; Antithrombin III Deficiency; Antithrombins; Arginine; Arterial Occlusive Diseases; Mice; Pipecolic Acids; Pulmonary Embolism; Rats; Rats, Inbred Strains; Sulfonamides; Thrombosis; Vena Cava, Inferior

1987